Literature DB >> 22548442

Activin A promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells.

Chantal Cerdan1, Brendan A S McIntyre, Rami Mechael, Marilyne Levadoux-Martin, Jiabi Yang, Jung Bok Lee, Mickie Bhatia.   

Abstract

The development of the hematopoietic system involves multiple cellular steps beginning with the formation of the mesoderm from the primitive streak, followed by emergence of precursor populations that become committed to either the endothelial or hematopoietic lineages. A number of growth factors such as activins and fibroblast growth factors (FGFs) are known to regulate the early specification of hematopoietic fated mesoderm, notably in amphibians. However, the potential roles of these factors in the development of mesoderm and subsequent hematopoiesis in the human have yet to be delineated. Defining the cellular and molecular mechanisms by which combinations of mesoderm-inducing factors regulate this stepwise process in human cells in vitro is central to effectively directing human embryonic stem cell (hESC) hematopoietic differentiation. Herein, using hESC-derived embryoid bodies (EBs), we show that Activin A, but not basic FGF/FGF2 (bFGF), promotes hematopoietic fated mesodermal specification from pluripotent human cells. The effect of Activin A treatment relies on the presence of bone morphogenetic protein 4 (BMP4) and both of the hematopoietic cytokines stem cell factor and fms-like tyrosine kinase receptor-3 ligand, and is the consequence of 2 separate mechanisms occurring at 2 different stages of human EB development from mesoderm to blood. While Activin A promotes the induction of mesoderm, as indicated by the upregulation of Brachyury expression, which represents the mesodermal precursor required for hematopoietic development, it also contributes to the expansion of cells already committed to a hematopoietic fate. As hematopoietic development requires the transition through a Brachyury+ intermediate, we demonstrate that hematopoiesis in hESCs is impaired by the downregulation of Brachyury, but is unaffected by its overexpression. These results demonstrate, for the first time, the functional significance of Brachyury in the developmental program of hematopoietic differentiation from hESCs and provide an in-depth understanding of the molecular cues that orchestrate stepwise development of hematopoiesis in a human system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548442      PMCID: PMC3464075          DOI: 10.1089/scd.2012.0053

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  62 in total

1.  Expression pattern of PAX3 and PAX6 genes during human embryogenesis.

Authors:  J Terzić; M Saraga-Babić
Journal:  Int J Dev Biol       Date:  1999-09       Impact factor: 2.203

Review 2.  The role of activin a in regulation of hemopoiesis.

Authors:  Yaron Shav-Tal; Dov Zipori
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

3.  Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation.

Authors:  Hans Jörg Fehling; Georges Lacaud; Atsushi Kubo; Marion Kennedy; Scott Robertson; Gordon Keller; Valerie Kouskoff
Journal:  Development       Date:  2003-09       Impact factor: 6.868

4.  Refinement of gene expression patterns in the early Xenopus embryo.

Authors:  Fiona C Wardle; James C Smith
Journal:  Development       Date:  2004-08-25       Impact factor: 6.868

5.  Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.

Authors:  Lisheng Wang; Li Li; Farbod Shojaei; Krysta Levac; Chantal Cerdan; Pablo Menendez; Tanya Martin; Anne Rouleau; Mickie Bhatia
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

6.  Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells.

Authors:  Kristin Chadwick; Lisheng Wang; Li Li; Pablo Menendez; Barbara Murdoch; Anne Rouleau; Mickie Bhatia
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

7.  Feeder-free growth of undifferentiated human embryonic stem cells.

Authors:  C Xu; M S Inokuma; J Denham; K Golds; P Kundu; J D Gold; M K Carpenter
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

8.  VEGF-A165 augments erythropoietic development from human embryonic stem cells.

Authors:  Chantal Cerdan; Anne Rouleau; Mickie Bhatia
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

9.  The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.

Authors:  Stella Pearson; Patrycja Sroczynska; Georges Lacaud; Valerie Kouskoff
Journal:  Development       Date:  2008-03-13       Impact factor: 6.868

10.  Development of definitive endoderm from embryonic stem cells in culture.

Authors:  Atsushi Kubo; Katsunori Shinozaki; John M Shannon; Valerie Kouskoff; Marion Kennedy; Savio Woo; Hans Joerg Fehling; Gordon Keller
Journal:  Development       Date:  2004-03-03       Impact factor: 6.868

View more
  11 in total

Review 1.  Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.

Authors:  Abhirath Parikh; Jincheng Wu; Robert M Blanton; Emmanuel S Tzanakakis
Journal:  Tissue Eng Part B Rev       Date:  2015-05-11       Impact factor: 6.389

2.  In vivo construction of lymphoid node by implantation of adipose-derived stromal cells with hydroxypropyl methyl cellulose hydrogel in BALB/c nude mice.

Authors:  Jing Zhang; Yuqiao Xu; Tao Liu; Jie Min; Yu Ma; Yongli Song; Jianrong Lu; Wenjuan Mi; Yingmei Wang; Hang Li; Wangzhou Li; Daqing Zhao
Journal:  Organogenesis       Date:  2019-08-26       Impact factor: 2.500

3.  BRACHYURY directs histone acetylation to target loci during mesoderm development.

Authors:  Arica Beisaw; Pavel Tsaytler; Frederic Koch; Sandra U Schmitz; Maria-Theodora Melissari; Anna D Senft; Lars Wittler; Tracie Pennimpede; Karol Macura; Bernhard G Herrmann; Phillip Grote
Journal:  EMBO Rep       Date:  2017-11-15       Impact factor: 8.807

4.  Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.

Authors:  J Jacob Wamsley; Manish Kumar; David F Allison; Sheena H Clift; Caitlyn M Holzknecht; Szymon J Szymura; Stephen A Hoang; Xiaojiang Xu; Christopher A Moskaluk; David R Jones; Stefan Bekiranov; Marty W Mayo
Journal:  Cancer Res       Date:  2014-11-28       Impact factor: 12.701

5.  Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors.

Authors:  Harsha Pawani; Punam Nagvenkar; Prasad Pethe; Deepa Bhartiya
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-01-04       Impact factor: 2.416

6.  ActivinA Induced SMAD1/5 Signaling in an iPSC Derived EC Model of Fibrodysplasia Ossificans Progressiva (FOP) Can Be Rescued by the Drug Candidate Saracatinib.

Authors:  Susanne Hildebrandt; Branka Kampfrath; Kristin Fischer; Laura Hildebrand; Julia Haupt; Harald Stachelscheid; Petra Knaus
Journal:  Stem Cell Rev Rep       Date:  2021-01-07       Impact factor: 5.739

7.  Reversible lineage-specific priming of human embryonic stem cells can be exploited to optimize the yield of differentiated cells.

Authors:  Jung Bok Lee; Monica Graham; Tony J Collins; Jong-Hee Lee; Seok-Ho Hong; Amie Jamie Mcnicol; Zoya Shapovalova; Mickie Bhatia
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

8.  Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions.

Authors:  Gene Uenishi; Derek Theisen; Jeong-Hee Lee; Akhilesh Kumar; Matt Raymond; Maxim Vodyanik; Scott Swanson; Ron Stewart; James Thomson; Igor Slukvin
Journal:  Stem Cell Reports       Date:  2014-10-23       Impact factor: 7.765

9.  Defining minimum essential factors to derive highly pure human endothelial cells from iPS/ES cells in an animal substance-free system.

Authors:  Yu-Ting Wu; Kuen-Jer Tsai; Chien-Yu Shih; Shiaw-Min Hwang; Ih-Jen Su; Po-Min Chiang
Journal:  Sci Rep       Date:  2015-04-13       Impact factor: 4.379

10.  R-spondin2 promotes hematopoietic differentiation of human pluripotent stem cells by activating TGF beta signaling.

Authors:  Yv Wang; Jie Gao; Hongtao Wang; Mengge Wang; Yuqi Wen; Jiaojiao Guo; Pei Su; Lihong Shi; Wen Zhou; Jiaxi Zhou
Journal:  Stem Cell Res Ther       Date:  2019-05-20       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.